96 related articles for article (PubMed ID: 25182141)
1. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis.
Kalantari S; Nafar M; Rutishauser D; Samavat S; Rezaei-Tavirani M; Yang H; Zubarev RA
BMC Nephrol; 2014 Sep; 15():141. PubMed ID: 25182141
[TBL] [Abstract][Full Text] [Related]
2. [Study of urinary markers of different podocytopathies by proteomic analysis].
Vinogradov AA; Chebotareva NV; Bugrova AE; Brzhozovskiy AG; Krasnova TN; Nasibullina KZ; Kononikhin AS; Moiseev SV
Ter Arkh; 2023 Aug; 95(6):457-461. PubMed ID: 38158963
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.
Trachtman H; Vento S; Herreshoff E; Radeva M; Gassman J; Stein DT; Savin VJ; Sharma M; Reiser J; Wei C; Somers M; Srivastava T; Gipson DS
BMC Nephrol; 2015 Jul; 16():111. PubMed ID: 26198842
[TBL] [Abstract][Full Text] [Related]
4. A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.
Trachtman H; Fervenza FC; Gipson DS; Heering P; Jayne DR; Peters H; Rota S; Remuzzi G; Rump LC; Sellin LK; Heaton JP; Streisand JB; Hard ML; Ledbetter SR; Vincenti F
Kidney Int; 2011 Jun; 79(11):1236-43. PubMed ID: 21368745
[TBL] [Abstract][Full Text] [Related]
5. Differentiating primary and secondary FSGS using non-invasive urine biomarkers.
Catanese L; Siwy J; Wendt R; Amann K; Beige J; Hendry B; Mischak H; Mullen W; Paterson I; Schiffer M; Wolf M; Rupprecht H
Clin Kidney J; 2024 Feb; 17(2):sfad296. PubMed ID: 38313685
[TBL] [Abstract][Full Text] [Related]
6. Identification of urine biomarkers of endometriosis-Protein mass spectrometry.
Višnić A; Barišić D; Čanadi Jurešić G; Sušanj Šepić T; Smiljan Severinski N
Am J Reprod Immunol; 2024 May; 91(5):e13856. PubMed ID: 38709906
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Individual Variation in the Urinary Proteome Revealed Significant Gender Differences.
Shao C; Zhao M; Chen X; Sun H; Yang Y; Xiao X; Guo Z; Liu X; Lv Y; Chen X; Sun W; Wu D; Gao Y
Mol Cell Proteomics; 2019 Jun; 18(6):1110-1122. PubMed ID: 30894400
[TBL] [Abstract][Full Text] [Related]
8. Nanoproteomic Approach for Isolation and Identification of Potential Biomarkers in Human Urine from Adults with Normal Weight, Overweight and Obesity.
Hernandez-Leon SG; Sarabia Sainz JA; Ramos-Clamont Montfort G; Huerta-Ocampo JÁ; Ballesteros MN; Guzman-Partida AM; Robles-Burgueño MDR; Vazquez-Moreno L
Molecules; 2021 Mar; 26(6):. PubMed ID: 33806905
[TBL] [Abstract][Full Text] [Related]
9. "Presumed" Primary Focal Segmental Glomerulosclerosis: A Novel Nuance for Steroid Therapy.
Glassock RJ; Fervenza FC
Kidney Int Rep; 2022 Jan; 7(1):9-12. PubMed ID: 35005308
[No Abstract] [Full Text] [Related]
10. Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.
Malone AF; Phelan PJ; Hall G; Cetincelik U; Homstad A; Alonso AS; Jiang R; Lindsey TB; Wu G; Sparks MA; Smith SR; Webb NJ; Kalra PA; Adeyemo AA; Shaw AS; Conlon PJ; Jennette JC; Howell DN; Winn MP; Gbadegesin RA
Kidney Int; 2014 Dec; 86(6):1253-9. PubMed ID: 25229338
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis.
Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH
Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681
[TBL] [Abstract][Full Text] [Related]
12. The current use of proteomics and metabolomics in glomerulonephritis: a systematic literature review.
Davies E; Chetwynd A; McDowell G; Rao A; Oni L
J Nephrol; 2024 Apr; ():. PubMed ID: 38689160
[TBL] [Abstract][Full Text] [Related]
13. Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.
Catanese L; Rupprecht H; Huber TB; Lindenmeyer MT; Hengel FE; Amann K; Wendt R; Siwy J; Mischak H; Beige J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542491
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy.
Hu Q; Yang Q; Gao H; Tian J; Che G
J Diabetes Investig; 2024 May; 15(5):572-583. PubMed ID: 38268239
[TBL] [Abstract][Full Text] [Related]
15. Machine learning models for predicting steroid-resistant of nephrotic syndrome.
Ye Q; Li Y; Liu H; Mao J; Jiang H
Front Immunol; 2023; 14():1090241. PubMed ID: 36776850
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic analysis of children FSGS FFPE tissues.
Ni J; Tian S; Bai L; Lv Q; Liu J; Liu J; Fang Y; Zhai Y; Shen Q; Rao J; Ding C; Xu H
BMC Pediatr; 2022 Dec; 22(1):707. PubMed ID: 36503536
[TBL] [Abstract][Full Text] [Related]
17. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers.
Taherkhani A; Farrokhi Yekta R; Mohseni M; Saidijam M; Arefi Oskouie A
Proteome Sci; 2019; 17():7. PubMed ID: 31889913
[TBL] [Abstract][Full Text] [Related]
19. Molecular stratification of idiopathic nephrotic syndrome.
Saleem MA
Nat Rev Nephrol; 2019 Dec; 15(12):750-765. PubMed ID: 31654044
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin sulfate degradation and eicosanoid metabolism pathways are impaired in focal segmental glomerulosclerosis: Experimental confirmation of an
Kalantari S; Naji M; Nafar M; Yazdani-Kachooei H; Borumandnia N; Parvin M
Bioimpacts; 2019; 9(2):89-95. PubMed ID: 31334040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
